Gene ontology categories predicted for the full length AA sequence, from most to least probable, are "immune response", "stress response" and "signal transduction".
These sequences were rank-ordered from most to least common and sequentially numbered to give every sequence a unique name.
The secondary purposes included comparing the impact of presenting information on risk of side effects in two different sequences, i.e. from most to least and from least to most severe, eliciting patient preference on risk communication, and exploring whether patients' usage of verbal descriptors of risk agrees with that of the EU.
Another aspect of information presentation concerns the sequence of presenting side effects, e.g. from most to least severe or the other way round.
In part 1 of the experiment, the patients received information about the risk of side effects in one of three formats (frequency, percentage and verbal descriptor) and in one of two sequences (from least to most severe and from most to least severe), and were asked about their willingness to participate.
The order of binding preference from most to least preferred for 2 and 3 for these sequences is as follows: DNA sequences 5, 2, 4, and 3. DNA sequence 2, the original hybrid sequence composed of the minor major minor groove bisintercalator binding sites, lacked a preferred purine-purine intercalation step.
Segment customers from most to least profitable.
Here they are in order from most to least significant.
Active molecules are ranked ordered from most to least potent (left to right).
In Table 10, the states are ranked from most to least preferred for each DM.
Then, the scaffolds were sorted by the scaffold frequency from most to least frequent.
